PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
Although we know lncRNAs play a role in cancer, the identification of clinically relevant and functional lncRNAs is lacking. Here, the authors identify 633 prognostic markers, 570 S-phase cancer-associated lncRNAs, and show SCAT7 regulates FGF/FGFR and PI3K/AKT/MAPK pathways via interaction with hnR...
Guardado en:
Autores principales: | Mohamad Moustafa Ali, Vijay Suresh Akhade, Subazini Thankaswamy Kosalai, Santhilal Subhash, Luisa Statello, Matthieu Meryet-Figuiere, Jonas Abrahamsson, Tanmoy Mondal, Chandrasekhar Kanduri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/157be40b73b2441180be0273025f743a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
por: Yongsheng Li, et al.
Publicado: (2020) -
A Pan-Cancer Landscape of HOX-Related lncRNAs and Their Association With Prognosis and Tumor Microenvironment
por: Wei Shao, et al.
Publicado: (2021) -
Dysregulation of lncRNAs in autoimmune neuropathies
por: Mahdi Gholipour, et al.
Publicado: (2021) -
Multi-Run Concrete Autoencoder to Identify Prognostic lncRNAs for 12 Cancers
por: Abdullah Al Mamun, et al.
Publicado: (2021) -
Pan-cancer analysis of non-oncogene addiction to DNA repair
por: Luis Bermúdez-Guzmán
Publicado: (2021)